8-K: Exicure Inc. Regains Nasdaq Compliance After Successful Equity Raise

Exicure Inc. has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement following a series of stock sales, increasing its equity to approximately $4.3 million.

Summary

• Exicure Inc. was previously notified by Nasdaq that it did not meet the minimum $2.5 million stockholders' equity requirement.
• The company's stockholders' deficit was $2.2 million as of March 31, 2024.
• Exicure was granted an extension until December 17, 2024, to regain compliance.
• To meet this requirement, Exicure executed several stock purchase agreements.
• On November 12, 2024, Exicure sold 433,000 shares to HiTron Systems Inc. at $3.00 per share, generating $1.3 million in net proceeds.
• On November 13, 2024, Exicure agreed to sell an additional 2,900,000 shares to HiTron for $8.7 million, also at $3.00 per share.
• On December 9, 2024, Exicure sold 433,332 shares to SangSangIn Investment & Securities Co., Ltd. at $4.61 per share, generating approximately $2 million in net proceeds.
• As a result of these transactions, Exicure's stockholders' equity is now approximately $4.3 million as of December 17, 2024.
• The company is awaiting confirmation from Nasdaq that it has met the Equity Requirement.

Sentiment

Score: 7

Explanation: The document indicates a positive outcome as the company has successfully regained Nasdaq compliance through a capital raise. However, the need for such measures suggests underlying financial challenges, hence the score is not higher.

Positives

• Exicure successfully raised capital through stock sales.
• The company has met the Nasdaq minimum stockholders' equity requirement.
• The company received a total of approximately $12 million in net proceeds from the stock sales.
• The pro forma balance sheet shows an increase in total assets from $10.163 million to $12.912 million.

Negatives

• Exicure was previously in non-compliance with Nasdaq's minimum stockholders' equity requirement.
• The company had a stockholders' deficit of $2.2 million as of March 31, 2024.
• The company had to undertake significant stock sales to regain compliance.

Risks

• The company is still awaiting confirmation from Nasdaq that it has met the Equity Requirement.
• The company's future performance is subject to risks and uncertainties as detailed in their annual report.
• The company's reliance on stock sales to meet compliance requirements may not be sustainable in the long term.

Future Outlook

The company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Requirement and will continue to operate as a listed company.

Management Comments

• The company has completed the transactions necessary to regain compliance with the Equity Requirement.

Industry Context

This announcement is relevant to the biotechnology industry, where companies often face challenges in maintaining sufficient capital and meeting listing requirements. Exicure's successful capital raise is a positive development for the company and its investors.

Comparison to Industry Standards

• Many small-cap biotech companies face similar challenges in maintaining Nasdaq listing compliance.
• Companies like Athersys and Ocugen have also faced similar issues with maintaining minimum equity requirements.
• The successful capital raise by Exicure is a positive sign, as many companies in the sector struggle to raise sufficient funds.
• The price per share of $3.00 and $4.61 is within the range of similar capital raises for companies in this sector.

Stakeholder Impact

• Shareholders should view the successful capital raise and Nasdaq compliance as a positive development.
• The company's employees may benefit from the increased financial stability.
• Customers and suppliers may have increased confidence in the company's long-term viability.

Next Steps

• The company awaits Nasdaq's confirmation that it has evidenced compliance with the Equity Requirement.

Key Dates

Keywords

stockholders' equity, Nasdaq compliance, capital raise, stock purchase agreement, equity requirement, Exicure Inc., HiTron Systems Inc., SangSangIn Investment & Securities Co., Ltd.